These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12900341)

  • 1. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Circulation; 2003 Aug; 108(7):808-13. PubMed ID: 12900341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Obstet Gynecol; 1997 Jul; 90(1):22-5. PubMed ID: 9207806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
    Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
    Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women.
    Wakatsuki A; Ikenoue N; Okatani Y; Fukaya T
    J Am Coll Cardiol; 2001 Feb; 37(2):425-30. PubMed ID: 11216957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.
    Yasui T; Uemura H; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Menopause; 2006; 13(2):314-22. PubMed ID: 16645545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
    Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
    Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.
    Aguilar-Salinas CA; Arita Melzer O; Sauque Reyna L; Lopez A; Velasco Perez ML; Guillen LE; Gomez Perez FJ; Rull Rodrigo JA
    Isr Med Assoc J; 2001 Feb; 3(2):137-43. PubMed ID: 11344825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.